These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres. Chapman AG; Dürmuller N; Lees GJ; Meldrum BS Neurosci Lett; 1989 Dec; 107(1-3):256-60. PubMed ID: 2515501 [TBL] [Abstract][Full Text] [Related]
45. Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP. Biggio G; Corda MG; Casu M; Gessa GL Naunyn Schmiedebergs Arch Pharmacol; 1978 Aug; 304(1):5-7. PubMed ID: 211448 [TBL] [Abstract][Full Text] [Related]
46. Amphetamine-induced locomotor activity and stereotypy after kainic acid lesions of the striatum. Mason ST; Sanberg PR; Fibiger HC Life Sci; 1978 Feb; 22(6):451-9. PubMed ID: 24160 [No Abstract] [Full Text] [Related]
47. Changes in cholinergic but not in GABAergic markers in amygdala, piriform cortex, and nucleus basalis of the rat brain following systemic administration of kainic acid. Schliebs R; Zivin M; Steinbach J; Rothe T J Neurochem; 1989 Jul; 53(1):212-8. PubMed ID: 2542459 [TBL] [Abstract][Full Text] [Related]
48. Increase in striatal [3H]muscimol binding following intrastriatal injection of kainic acid: a denervation supersensitivity phenomenon. Kuriyama K; Kurihara E; Ito Y; Yoneda Y J Neurochem; 1980 Aug; 35(2):343-8. PubMed ID: 6256483 [TBL] [Abstract][Full Text] [Related]
49. Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease. Coyle JT; Ferkany JW; Zaczek R Neurobehav Toxicol Teratol; 1983; 5(6):617-24. PubMed ID: 6142425 [TBL] [Abstract][Full Text] [Related]
50. Structure-activity relations for the neurotoxicity of kainic acid derivatives and glutamate analogues. Schwarcz R; Scholz D; Coyle JT Neuropharmacology; 1978 Feb; 17(2):145-51. PubMed ID: 634450 [No Abstract] [Full Text] [Related]
51. Age-related alterations in the rodent brain cholinergic system and behavior. Strong R; Hicks P; Hsu L; Bartus RT; Enna SJ Neurobiol Aging; 1980; 1(1):59-63. PubMed ID: 7266736 [TBL] [Abstract][Full Text] [Related]
52. Kainic acid and neurotransmitter interactions in the basal ganglia. McGeer PL; McGeer EG; Innanen VT Adv Biochem Psychopharmacol; 1980; 24():185-91. PubMed ID: 6105774 [No Abstract] [Full Text] [Related]
53. Cortical modulation of cholinergic neurons in the striatum. Simon JR Life Sci; 1982 Oct; 31(14):1501-8. PubMed ID: 7144438 [TBL] [Abstract][Full Text] [Related]
54. Kainic acid lesion of mouse striatum: effects on energy metabolites. Retz KC; Coyle JT Life Sci; 1980 Dec 22-29; 27(25-26):2495-500. PubMed ID: 6111722 [No Abstract] [Full Text] [Related]
55. Modification of drug-induced tremor by systemic administration of kainic acid and quisqualic acid in mice. Shinozaki H; Hirate K; Ishida M Neuropharmacology; 1987 Jan; 26(1):9-17. PubMed ID: 3550515 [TBL] [Abstract][Full Text] [Related]
56. Chronic taurine effects on various neurochemical indices in control and kainic acid-lesioned neostriatum. Sanberg PR; Staines W; McGeer EG Brain Res; 1979 Feb; 161(2):367-70. PubMed ID: 31967 [No Abstract] [Full Text] [Related]